Last updated on July 2010

A Pilot Study of Filtrum-STI in Children With Viral Gastroenteritis


Brief description of study

This is a phase II double blind multicenter randomized placebo-controled clinical study aimed to find out whether treatment with Filtrum-STI (orally administered 0,4g tablets) is safe and effective in children with viral gastroenteritis. Filtrum-STI (lignin hydrolytic) is a drug with a high absorbing ability, that binds and eliminates toxins, pathogenic microorganisms and viruses. Filtrum-STI is inoffensive for mucous membranes, enhances colonic propulsion and improves its natural microflora. The drug is not toxic and well combines with other medication

Clinical Study Identifier: NCT01113346

Contact Investigators or Research Sites near you

Start Over

Larisa Titova, MD, PhD

Arhangelsk Regional Children's Clinical Hospital named after P.G. Vizshletsov
Arhangelsk, Russian Federation
  Connect »

Elena Meskina, MD, DrSc

St. Vladimir Children's Moscow Clinical Hospital
Moscow, Russian Federation
  Connect »